Jerry Stitzel
Concepts (382)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 67 | 2025 | 337 | 8.630 |
Why?
| | Nicotine | 47 | 2026 | 337 | 7.810 |
Why?
| | Nicotinic Agonists | 18 | 2025 | 140 | 2.830 |
Why?
| | Tobacco Use Disorder | 19 | 2025 | 217 | 2.560 |
Why?
| | Prenatal Exposure Delayed Effects | 6 | 2026 | 665 | 1.890 |
Why?
| | Neurodevelopmental Disorders | 3 | 2026 | 239 | 1.770 |
Why?
| | Smoking | 15 | 2023 | 1486 | 1.170 |
Why?
| | Polymorphism, Single Nucleotide | 22 | 2023 | 2240 | 1.140 |
Why?
| | Brain | 22 | 2020 | 2991 | 1.070 |
Why?
| | Corpus Striatum | 6 | 2026 | 181 | 1.030 |
Why?
| | Polymorphism, Genetic | 12 | 2014 | 612 | 0.990 |
Why?
| | Mice | 61 | 2026 | 18297 | 0.970 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 12 | 2017 | 105 | 0.970 |
Why?
| | Receptors, Dopamine D1 | 1 | 2026 | 35 | 0.910 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 712 | 0.910 |
Why?
| | Mice, Inbred C3H | 15 | 2015 | 252 | 0.830 |
Why?
| | Bungarotoxins | 19 | 2014 | 45 | 0.790 |
Why?
| | Hippocampus | 10 | 2019 | 989 | 0.770 |
Why?
| | Protein Subunits | 8 | 2017 | 225 | 0.750 |
Why?
| | Animals | 67 | 2026 | 38107 | 0.750 |
Why?
| | Melatonin | 2 | 2015 | 165 | 0.730 |
Why?
| | Mice, Inbred C57BL | 23 | 2026 | 6034 | 0.720 |
Why?
| | Substance Withdrawal Syndrome | 4 | 2025 | 185 | 0.710 |
Why?
| | Nerve Tissue Proteins | 9 | 2018 | 597 | 0.660 |
Why?
| | Mice, Inbred DBA | 17 | 2015 | 186 | 0.610 |
Why?
| | Synaptosomes | 6 | 2014 | 32 | 0.600 |
Why?
| | Neurons | 4 | 2018 | 1668 | 0.580 |
Why?
| | Sleep | 5 | 2025 | 896 | 0.580 |
Why?
| | Frontal Lobe | 2 | 2019 | 159 | 0.580 |
Why?
| | Genetic Variation | 9 | 2022 | 996 | 0.560 |
Why?
| | Nicotinic Antagonists | 7 | 2017 | 37 | 0.560 |
Why?
| | Protein Precursors | 1 | 2019 | 127 | 0.560 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2019 | 155 | 0.550 |
Why?
| | DNA Methylation | 2 | 2021 | 725 | 0.550 |
Why?
| | Choice Behavior | 5 | 2015 | 179 | 0.540 |
Why?
| | Serine | 1 | 2018 | 142 | 0.530 |
Why?
| | Gene Expression Regulation | 7 | 2013 | 2599 | 0.530 |
Why?
| | Wakefulness | 1 | 2018 | 170 | 0.510 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 487 | 0.500 |
Why?
| | Species Specificity | 14 | 2012 | 543 | 0.490 |
Why?
| | Motor Activity | 12 | 2022 | 704 | 0.480 |
Why?
| | Receptors, Melatonin | 1 | 2015 | 2 | 0.440 |
Why?
| | Ethanol | 6 | 2022 | 630 | 0.440 |
Why?
| | Glucocorticoids | 1 | 2019 | 536 | 0.430 |
Why?
| | Gene Expression | 7 | 2015 | 1463 | 0.430 |
Why?
| | Pregnancy | 8 | 2026 | 7230 | 0.430 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 314 | 0.420 |
Why?
| | GABA-B Receptor Agonists | 1 | 2014 | 5 | 0.420 |
Why?
| | Sensory Gating | 1 | 2015 | 45 | 0.420 |
Why?
| | Receptors, GABA-B | 1 | 2014 | 10 | 0.420 |
Why?
| | Baclofen | 1 | 2014 | 21 | 0.410 |
Why?
| | Drinking | 3 | 2015 | 44 | 0.400 |
Why?
| | Polymorphism, Restriction Fragment Length | 7 | 2007 | 57 | 0.400 |
Why?
| | Disease Models, Animal | 11 | 2026 | 4580 | 0.390 |
Why?
| | Behavior, Animal | 7 | 2019 | 531 | 0.390 |
Why?
| | Male | 55 | 2026 | 73396 | 0.380 |
Why?
| | Alcohol Drinking | 5 | 2022 | 850 | 0.380 |
Why?
| | Acetylcholine | 7 | 2012 | 209 | 0.370 |
Why?
| | Schizophrenia | 4 | 2017 | 537 | 0.370 |
Why?
| | Female | 53 | 2026 | 79499 | 0.350 |
Why?
| | Gene Targeting | 2 | 2011 | 76 | 0.350 |
Why?
| | Mice, Inbred Strains | 10 | 2005 | 384 | 0.340 |
Why?
| | Calcium | 3 | 2015 | 1181 | 0.340 |
Why?
| | Mice, Knockout | 11 | 2025 | 3125 | 0.340 |
Why?
| | Circadian Rhythm | 2 | 2015 | 515 | 0.340 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 5 | 2018 | 292 | 0.340 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2012 | 2022 | 0.330 |
Why?
| | Drug Discovery | 1 | 2011 | 154 | 0.310 |
Why?
| | Gene Knock-In Techniques | 1 | 2010 | 60 | 0.300 |
Why?
| | Administration, Oral | 4 | 2018 | 872 | 0.300 |
Why?
| | Rubidium | 4 | 2002 | 11 | 0.290 |
Why?
| | Pyridines | 5 | 2018 | 610 | 0.290 |
Why?
| | Phenotype | 12 | 2023 | 3206 | 0.290 |
Why?
| | Seizures | 4 | 2007 | 489 | 0.290 |
Why?
| | Oocytes | 1 | 2010 | 186 | 0.280 |
Why?
| | Chromosome Mapping | 2 | 2006 | 508 | 0.280 |
Why?
| | Taste | 2 | 2015 | 237 | 0.270 |
Why?
| | Promoter Regions, Genetic | 4 | 2015 | 1242 | 0.270 |
Why?
| | Genetic Predisposition to Disease | 8 | 2022 | 2488 | 0.270 |
Why?
| | Signal Transduction | 3 | 2019 | 5246 | 0.270 |
Why?
| | Brain Chemistry | 2 | 2007 | 122 | 0.270 |
Why?
| | Chlorisondamine | 1 | 2007 | 3 | 0.260 |
Why?
| | Central Nervous System Depressants | 3 | 2005 | 83 | 0.260 |
Why?
| | Genes, fos | 1 | 2007 | 26 | 0.260 |
Why?
| | Aging | 2 | 2022 | 1996 | 0.250 |
Why?
| | Corticosterone | 2 | 2019 | 241 | 0.250 |
Why?
| | Neural Inhibition | 4 | 2017 | 186 | 0.240 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2134 | 0.240 |
Why?
| | Genotype | 14 | 2014 | 1879 | 0.240 |
Why?
| | Quantitative Trait Loci | 2 | 2015 | 388 | 0.230 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 159 | 0.230 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 15 | 0.220 |
Why?
| | Anxiety | 1 | 2012 | 1125 | 0.210 |
Why?
| | Genome-Wide Association Study | 6 | 2023 | 1537 | 0.210 |
Why?
| | Up-Regulation | 2 | 2018 | 841 | 0.210 |
Why?
| | Multifactorial Inheritance | 2 | 2023 | 243 | 0.200 |
Why?
| | DNA-Binding Proteins | 2 | 2022 | 1468 | 0.200 |
Why?
| | Choline | 2 | 2015 | 136 | 0.190 |
Why?
| | Astrocytes | 1 | 2025 | 229 | 0.190 |
Why?
| | Maze Learning | 3 | 2012 | 106 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2025 | 441 | 0.190 |
Why?
| | Epistasis, Genetic | 1 | 2023 | 67 | 0.190 |
Why?
| | Humans | 40 | 2026 | 146342 | 0.190 |
Why?
| | Chronobiology Disorders | 1 | 2022 | 17 | 0.180 |
Why?
| | Genetic Markers | 2 | 2020 | 340 | 0.180 |
Why?
| | Internationality | 1 | 2022 | 156 | 0.180 |
Why?
| | Tobacco Use | 1 | 2022 | 67 | 0.170 |
Why?
| | Quinolizines | 3 | 2010 | 9 | 0.170 |
Why?
| | Azocines | 3 | 2010 | 8 | 0.170 |
Why?
| | Maternal Inheritance | 1 | 2021 | 16 | 0.170 |
Why?
| | Alkaloids | 3 | 2010 | 28 | 0.170 |
Why?
| | Benzazepines | 2 | 2012 | 36 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2003 | 253 | 0.170 |
Why?
| | Varenicline | 2 | 2012 | 29 | 0.160 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2014 | 195 | 0.160 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 221 | 0.160 |
Why?
| | Quinoxalines | 2 | 2012 | 65 | 0.160 |
Why?
| | Muscle Proteins | 1 | 2022 | 242 | 0.160 |
Why?
| | Radioligand Assay | 3 | 2012 | 35 | 0.160 |
Why?
| | Histone Deacetylase 2 | 1 | 2020 | 10 | 0.160 |
Why?
| | Dopamine | 3 | 2019 | 295 | 0.160 |
Why?
| | Alzheimer Disease | 2 | 2022 | 641 | 0.150 |
Why?
| | Electroencephalography | 2 | 2025 | 576 | 0.150 |
Why?
| | Dioxygenases | 1 | 2020 | 36 | 0.150 |
Why?
| | Amino Acid Substitution | 3 | 2009 | 297 | 0.150 |
Why?
| | Methyl-CpG-Binding Protein 2 | 1 | 2020 | 24 | 0.150 |
Why?
| | Cell Line | 6 | 2017 | 2814 | 0.150 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 38 | 0.150 |
Why?
| | Furin | 1 | 2019 | 12 | 0.150 |
Why?
| | Self Administration | 3 | 2025 | 121 | 0.150 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2019 | 25 | 0.150 |
Why?
| | Transcriptome | 2 | 2023 | 1068 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 90 | 0.150 |
Why?
| | Aequorin | 2 | 2012 | 2 | 0.150 |
Why?
| | Muscle, Skeletal | 1 | 2010 | 1818 | 0.150 |
Why?
| | Sexual Maturation | 1 | 2019 | 49 | 0.150 |
Why?
| | Body Temperature | 8 | 2015 | 228 | 0.140 |
Why?
| | Gene-Environment Interaction | 2 | 2018 | 190 | 0.140 |
Why?
| | Sleep, REM | 1 | 2018 | 45 | 0.140 |
Why?
| | Visual Cortex | 1 | 2019 | 84 | 0.140 |
Why?
| | Sex Factors | 3 | 2012 | 2107 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2018 | 371 | 0.130 |
Why?
| | Myocarditis | 1 | 2018 | 103 | 0.130 |
Why?
| | Autoradiography | 3 | 2009 | 65 | 0.130 |
Why?
| | Sex Characteristics | 4 | 2025 | 801 | 0.130 |
Why?
| | Acoustic Stimulation | 3 | 2015 | 325 | 0.120 |
Why?
| | Cytochrome P-450 CYP2A6 | 1 | 2016 | 8 | 0.120 |
Why?
| | Mutation | 4 | 2022 | 4093 | 0.120 |
Why?
| | Proto-Oncogene Proteins | 1 | 2020 | 616 | 0.120 |
Why?
| | Pyramidal Cells | 1 | 2017 | 80 | 0.120 |
Why?
| | Genetic Linkage | 1 | 1996 | 271 | 0.120 |
Why?
| | HEK293 Cells | 3 | 2015 | 750 | 0.120 |
Why?
| | Alleles | 4 | 2013 | 907 | 0.110 |
Why?
| | Time Factors | 6 | 2018 | 7109 | 0.110 |
Why?
| | Substance-Related Disorders | 1 | 2005 | 1100 | 0.110 |
Why?
| | Cerebral Cortex | 3 | 2009 | 485 | 0.110 |
Why?
| | Analysis of Variance | 2 | 2012 | 1298 | 0.110 |
Why?
| | Receptor, Melatonin, MT1 | 1 | 2015 | 6 | 0.110 |
Why?
| | Down Syndrome | 1 | 2022 | 529 | 0.110 |
Why?
| | Cigarette Smoking | 1 | 2016 | 103 | 0.110 |
Why?
| | Mesencephalon | 1 | 2015 | 65 | 0.110 |
Why?
| | Isoxazoles | 1 | 2015 | 57 | 0.110 |
Why?
| | Autoreceptors | 1 | 2014 | 4 | 0.110 |
Why?
| | Pyrethrins | 1 | 2014 | 8 | 0.100 |
Why?
| | Potassium Chloride | 1 | 2014 | 41 | 0.100 |
Why?
| | Social Behavior | 1 | 2017 | 279 | 0.100 |
Why?
| | Conotoxins | 2 | 2004 | 17 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 902 | 0.100 |
Why?
| | Macrophages, Alveolar | 1 | 2017 | 377 | 0.100 |
Why?
| | Calcineurin Inhibitors | 1 | 2014 | 67 | 0.100 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 122 | 0.100 |
Why?
| | Heterozygote | 1 | 2015 | 311 | 0.100 |
Why?
| | Neurogenesis | 1 | 2015 | 158 | 0.100 |
Why?
| | Auditory Perception | 1 | 2015 | 107 | 0.100 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 325 | 0.100 |
Why?
| | Base Sequence | 4 | 2013 | 2123 | 0.100 |
Why?
| | Crosses, Genetic | 2 | 2006 | 120 | 0.100 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 58 | 0.100 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 339 | 0.100 |
Why?
| | Presynaptic Terminals | 1 | 2014 | 89 | 0.100 |
Why?
| | DNA, Intergenic | 1 | 2013 | 25 | 0.100 |
Why?
| | In Situ Hybridization | 3 | 2003 | 317 | 0.100 |
Why?
| | Patch-Clamp Techniques | 2 | 2004 | 288 | 0.100 |
Why?
| | Haplotypes | 4 | 2018 | 506 | 0.100 |
Why?
| | Protein Kinase C | 1 | 2014 | 250 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 974 | 0.090 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 152 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1041 | 0.090 |
Why?
| | Permeability | 1 | 2012 | 166 | 0.090 |
Why?
| | Dihydro-beta-Erythroidine | 2 | 2010 | 6 | 0.090 |
Why?
| | Rubidium Radioisotopes | 4 | 2004 | 9 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2012 | 279 | 0.080 |
Why?
| | Transfection | 3 | 2013 | 916 | 0.080 |
Why?
| | Food Preferences | 1 | 2012 | 126 | 0.080 |
Why?
| | Gene Frequency | 2 | 2009 | 496 | 0.080 |
Why?
| | Alcoholism | 3 | 2008 | 830 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2018 | 1215 | 0.080 |
Why?
| | Iodine Radioisotopes | 2 | 2009 | 139 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 368 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2092 | 0.080 |
Why?
| | Decamethonium Compounds | 1 | 2010 | 1 | 0.080 |
Why?
| | Hexamethonium | 1 | 2010 | 5 | 0.080 |
Why?
| | Mecamylamine | 1 | 2010 | 6 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 846 | 0.080 |
Why?
| | Xenopus laevis | 1 | 2010 | 101 | 0.080 |
Why?
| | Genetic Association Studies | 3 | 2018 | 379 | 0.070 |
Why?
| | Electrophysiology | 1 | 2010 | 219 | 0.070 |
Why?
| | Animals, Newborn | 1 | 2012 | 888 | 0.070 |
Why?
| | Organ Specificity | 1 | 2010 | 307 | 0.070 |
Why?
| | Dithiothreitol | 2 | 1988 | 19 | 0.070 |
Why?
| | Rats | 5 | 2013 | 5586 | 0.070 |
Why?
| | Risk | 3 | 2019 | 920 | 0.070 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2008 | 40 | 0.070 |
Why?
| | Luciferases | 3 | 2013 | 153 | 0.070 |
Why?
| | Columbidae | 1 | 2007 | 31 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2025 | 4118 | 0.060 |
Why?
| | Europe | 2 | 2022 | 421 | 0.060 |
Why?
| | Epilepsy | 2 | 2012 | 400 | 0.060 |
Why?
| | Mice, Congenic | 1 | 2006 | 23 | 0.060 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 132 | 0.060 |
Why?
| | Lod Score | 1 | 2006 | 64 | 0.060 |
Why?
| | RNA, Messenger | 4 | 2015 | 2791 | 0.060 |
Why?
| | Drug Interactions | 2 | 2004 | 405 | 0.060 |
Why?
| | RNA | 2 | 2010 | 926 | 0.060 |
Why?
| | Drinking Behavior | 1 | 2005 | 15 | 0.050 |
Why?
| | Cadmium Chloride | 1 | 2004 | 4 | 0.050 |
Why?
| | Ryanodine | 1 | 2004 | 15 | 0.050 |
Why?
| | Age of Onset | 2 | 2020 | 558 | 0.050 |
Why?
| | Macrocyclic Compounds | 1 | 2004 | 16 | 0.050 |
Why?
| | Reflex, Startle | 5 | 2017 | 75 | 0.050 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 90 | 0.050 |
Why?
| | Thalamus | 2 | 2009 | 134 | 0.050 |
Why?
| | Oxazoles | 1 | 2004 | 48 | 0.050 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 124 | 0.050 |
Why?
| | Snails | 1 | 2004 | 40 | 0.050 |
Why?
| | Age Factors | 1 | 2012 | 3347 | 0.050 |
Why?
| | Binding, Competitive | 3 | 2003 | 185 | 0.050 |
Why?
| | Extracellular Space | 1 | 2004 | 118 | 0.050 |
Why?
| | Algorithms | 1 | 2012 | 1849 | 0.050 |
Why?
| | Menthol | 1 | 2024 | 11 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2004 | 278 | 0.050 |
Why?
| | Adult | 12 | 2016 | 41087 | 0.050 |
Why?
| | Injections, Intraperitoneal | 2 | 2001 | 115 | 0.050 |
Why?
| | Mice, 129 Strain | 2 | 2015 | 83 | 0.050 |
Why?
| | Sequence Analysis | 1 | 2003 | 32 | 0.050 |
Why?
| | Threonine | 1 | 2003 | 43 | 0.050 |
Why?
| | Risk Factors | 5 | 2022 | 10921 | 0.050 |
Why?
| | Electroporation | 1 | 2003 | 43 | 0.050 |
Why?
| | Tobacco Smoking | 1 | 2023 | 29 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2003 | 360 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2003 | 188 | 0.050 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2022 | 19 | 0.050 |
Why?
| | Middle Aged | 9 | 2019 | 36619 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 124 | 0.050 |
Why?
| | Alanine | 1 | 2003 | 171 | 0.050 |
Why?
| | Exons | 1 | 2003 | 361 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 408 | 0.040 |
Why?
| | DNA | 3 | 2010 | 1421 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3416 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2024 | 294 | 0.040 |
Why?
| | Biological Transport, Active | 1 | 2001 | 69 | 0.040 |
Why?
| | Genetic Loci | 1 | 2022 | 273 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 823 | 0.040 |
Why?
| | Serum Albumin, Bovine | 1 | 2001 | 63 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1177 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2001 | 269 | 0.040 |
Why?
| | Interneurons | 1 | 2001 | 124 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2004 | 2838 | 0.040 |
Why?
| | Injections, Intraventricular | 1 | 2000 | 60 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 319 | 0.040 |
Why?
| | Adolescent | 7 | 2019 | 22557 | 0.040 |
Why?
| | Odds Ratio | 2 | 2016 | 1077 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1761 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 82 | 0.040 |
Why?
| | Hybridization, Genetic | 1 | 2000 | 75 | 0.040 |
Why?
| | Hyperkinesis | 1 | 2019 | 16 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2005 | 692 | 0.040 |
Why?
| | Cattle | 1 | 2001 | 940 | 0.040 |
Why?
| | Methylphenidate | 1 | 2019 | 48 | 0.030 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 59 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2000 | 185 | 0.030 |
Why?
| | Protective Factors | 1 | 2018 | 97 | 0.030 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 260 | 0.030 |
Why?
| | Autophagosomes | 1 | 2017 | 20 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 1999 | 1244 | 0.030 |
Why?
| | Protein Binding | 1 | 2003 | 2244 | 0.030 |
Why?
| | Prepulse Inhibition | 1 | 2017 | 12 | 0.030 |
Why?
| | Inflammasomes | 1 | 2018 | 145 | 0.030 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2017 | 36 | 0.030 |
Why?
| | Kinetics | 4 | 2004 | 1553 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1996 | 162 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3545 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 397 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 345 | 0.030 |
Why?
| | Young Adult | 4 | 2016 | 14330 | 0.030 |
Why?
| | Binding Sites | 3 | 2007 | 1309 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2009 | 2675 | 0.030 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2015 | 50 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 508 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2017 | 163 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 290 | 0.030 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 422 | 0.030 |
Why?
| | DNA Primers | 2 | 2008 | 487 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 415 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 928 | 0.030 |
Why?
| | Transcription Factors | 1 | 2022 | 1730 | 0.030 |
Why?
| | Mice, Inbred AKR | 2 | 2003 | 35 | 0.020 |
Why?
| | Mice, Inbred A | 2 | 2003 | 47 | 0.020 |
Why?
| | NF-kappa B | 1 | 2017 | 674 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2013 | 90 | 0.020 |
Why?
| | Down-Regulation | 1 | 2015 | 614 | 0.020 |
Why?
| | Cell Movement | 1 | 2017 | 951 | 0.020 |
Why?
| | Lactation | 1 | 2014 | 193 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 2008 | 1031 | 0.020 |
Why?
| | Adolescent Development | 1 | 2012 | 72 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3647 | 0.020 |
Why?
| | Aged | 3 | 2018 | 26432 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8391 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1532 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4595 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2919 | 0.020 |
Why?
| | Respiration | 3 | 2002 | 208 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 373 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2014 | 587 | 0.020 |
Why?
| | Ligands | 2 | 2003 | 678 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4351 | 0.020 |
Why?
| | Dizziness | 1 | 2010 | 93 | 0.020 |
Why?
| | Receptors, Muscarinic | 1 | 1989 | 21 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2012 | 216 | 0.020 |
Why?
| | Heart Rate | 4 | 2002 | 846 | 0.020 |
Why?
| | Alkylation | 1 | 1988 | 27 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 1989 | 176 | 0.020 |
Why?
| | Disulfides | 1 | 1988 | 93 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2008 | 329 | 0.020 |
Why?
| | Receptors, Opioid | 1 | 1987 | 21 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 128 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 385 | 0.020 |
Why?
| | Family Health | 1 | 2008 | 194 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 517 | 0.020 |
Why?
| | MicroRNAs | 1 | 2013 | 699 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 168 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 135 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1327 | 0.010 |
Why?
| | Prospective Studies | 1 | 2018 | 8123 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2013 | 1982 | 0.010 |
Why?
| | Logistic Models | 1 | 2010 | 2126 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2008 | 1543 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2921 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 1988 | 1075 | 0.010 |
Why?
| | Receptors, Neurotransmitter | 1 | 2003 | 20 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 526 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 442 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6460 | 0.010 |
Why?
| | Substantia Nigra | 1 | 2003 | 64 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2003 | 290 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 853 | 0.010 |
Why?
| | Drug Tolerance | 3 | 1987 | 100 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 663 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1361 | 0.010 |
Why?
| | Cell Count | 1 | 2001 | 315 | 0.010 |
Why?
| | Veratridine | 1 | 2000 | 5 | 0.010 |
Why?
| | Infant | 1 | 2015 | 10114 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 52 | 0.010 |
Why?
| | Drug Resistance | 1 | 2001 | 145 | 0.010 |
Why?
| | Hypothermia | 1 | 2001 | 53 | 0.010 |
Why?
| | United States | 1 | 2018 | 16136 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2001 | 202 | 0.010 |
Why?
| | Potassium | 1 | 2000 | 151 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11913 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2001 | 339 | 0.010 |
Why?
| | Genetic Testing | 1 | 2001 | 492 | 0.010 |
Why?
| | Cohort Studies | 1 | 2009 | 6077 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2001 | 1712 | 0.010 |
Why?
| | Child | 1 | 2015 | 22693 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 11821 | 0.010 |
Why?
| | Quinuclidinyl Benzilate | 1 | 1989 | 2 | 0.000 |
Why?
| | Dithionitrobenzoic Acid | 1 | 1986 | 3 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1986 | 316 | 0.000 |
Why?
| | Infusions, Intravenous | 1 | 1987 | 432 | 0.000 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 105 | 0.000 |
Why?
| | Hot Temperature | 1 | 1986 | 396 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1986 | 721 | 0.000 |
Why?
|
|
Stitzel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|